Skip links

Who We Are

This post is also available in: 한국어 (Korean)

Who We Are

medical-procedure-image

ClariPi Inc. was founded in February 2015 to provide innovative solutions for the unmet needs in medical imaging fields through the convergence of intelligent big data computing and medical imaging technologies. Our products were born through a long-term collaborative research between engineering and medical experts. Our products were designed to help medical imaging experts make confident decisions and clearer information with convenient decision guidance. We are providing innovative solutions to help medical experts cope with the rapidly changing landscape of 21st century healthcare services.

Jong-Hyo-Kim-CO-CEO-CTO-ClariPi

Jong Hyo, Kim

CO-CEO & CTO

Experience

Holds concurrent position as a professor at the Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University.

ClariCT.AI is an innovative vendor-neutral CT denoising solution based on Deep Learning technology. ClariCT.Al’s unique Deep-learned Clarity Engine clears CT noise, and turns an existing CT into a novel AI-empowered CT using only DICOM standard. ClariCT.AI provides multiple Deep Learning Models pertained with millions of images for different organs at varying noise levels from most existing scanner models, which is able to distinguish anatomical structures from thousands of different noise patterns and to serve noise-clean high-quality images. Because of the powerful denoising performance, when using ultra-low-dose, ClariCT.AI offers image quality comparable to high-dose CT images. ClariCT.AI removes strong noise and artifacts without suffering distortion and plastic appearance.

Hyun Sook, Park

CO-CEO

We specialize in medical imaging diagnostic solutions based on artificial intelligence. The best experts in the field gathered to develop various medical imaging diagnostic solutions by integrating artificial intelligence image processing and big data technology. ClariCT.AI, our flagship product, is an ultra-low-dose CT image denoising solution created through deep learning based on high-quality big data.

In addition, we are developing various diagnostic solutions for emphysema, breast density, abdominal metabolic syndrome, and liver fat by using artificial intelligence CT image processing technology. All employees of ClariPi will do their best to continuously provide innovative artificial intelligence medical imaging solutions that contribute to and “for the health and happiness of mankind”.

Hyun Sook-CO-CEO-ClariPi

Our History

  • 2015

    one

    This post is also available in: 한국어 (Korean)

    ClariPi Inc. founded

    Acquired 3 key patents

  • 2016

    two

    This post is also available in: 한국어 (Korean)

    Established a sinogram synthesis-based ultra-low dose CT simulation platform

    Created the world’s largest database for paired standard and ultra-low dose CT image

  • 2017

    Three

    This post is also available in: 한국어 (Korean)

    Began training of AI models for CT denoising with the established paired CT database

    Developed Clarity engine, selected set of the best performing CT denoising AI models

  • 2018

    Four

    This post is also available in: 한국어 (Korean)

    Developed the world’s first AI-powered CT denoising solution product, ClariCT.AI

    ClariCT.AI acquired MFDS approval

    Debuted at RSNA

  • 2019

    Five

    This post is also available in: 한국어 (Korean)

    ClariCT.AI acquired FDA clearance and CE certification

    Exhibited at SIIM and RSNA AI-showcase

    Additional patents applied and registered

  • 2020

    Six

    This post is also available in: 한국어 (Korean)

    Exhibited at Arab Health exhibition

    Showcased at ECR, Medica, and RSNA virtual exhibition

    ClariCT.AI OEM export in Europe

    ClariPulmo and ClariSigman acquired CE certification

  • 2021

    Seven

    This post is also available in: 한국어 (Korean)

    Stay tuned!

What Our Clients Say